Publication:
An N-nitrosating metalloenzyme constructs the pharmacophore of streptozotocin

Thumbnail Image

Date

2019-02

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Science and Business Media LLC
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Ng, T.L., Rohac, R., Mitchell, A.J. et al. An N-nitrosating metalloenzyme constructs the pharmacophore of streptozotocin. Nature 566, 94–99 (2019). https://doi.org/10.1038/s41586-019-0894-z

Research Data

Abstract

N-nitroso-containing small molecules, such as the bacterial natural product streptozotocin, are prominent carcinogens as well as important cancer chemotherapeutics. Despite this functional group’s significant impact on human health, dedicated enzymes involved in N-nitroso assembly have not been identified. Here, we describe a metalloenzyme from streptozotocin biosynthesis (SznF) that catalyzes an unprecedented oxidative rearrangement of the guanidine group of Nw-methyl-L-arginine to generate an N-nitrosourea product. Structural characterization and mutagenesis of SznF uncovered two separate active sites that promote distinct steps in this transformation using different iron-containing metallocofactors. The discovery of this biosynthetic reaction, which has little precedent in enzymology or organic synthesis, expands the catalytic capabilities of non-heme iron-dependent enzymes to include N–N bond formation. We find biosynthetic gene clusters encoding SznF homologs are widely distributed among bacteria, including environmental organisms, plant symbionts, and human pathogens, suggesting an unexpectedly diverse and uncharacterized microbial reservoir of bioactive N-nitroso metabolites.

Description

Other Available Sources

Keywords

Multidisciplinary

Terms of Use

Metadata Only

Endorsement

Review

Supplemented By

Referenced By

Related Stories